Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 33 results.
User Information
Export Records
  1. 1.   Histidine Tag-Specific PEGylation Improves the Circulating Half-Life of TIMP2
  2. Toor, Jack; Grabowska, Wiktoria R; Johnson, Adam L; Jones,Jane; Stetler-Stevenson, William G; Khalili, Hanieh; Peeney, David
  3. ACS Applied Bio Materials. 2025, Feb 21;
  1. 2.   Extracellular Matrix Limits Nanoparticle Diffusion and Cellular Uptake in a Tissue-Specific Manner
  2. Cahn,Devorah; Stern, Alexa; Buckenmeyer,Michael; Wolf,Matthew; Duncan, Gregg A
  3. ACS Nano. 2024, Nov 05;
  1. 3.   Nano-mupirocin as tumor-targeted antibiotic: Physicochemical, immunotoxicological and pharmacokinetic characterization, and effect on gut microbiome
  2. Cern, Ahuva; Skoczen,Sarah; Snapp, Kelsie S; Hod, Atara; Zilbersheid, Daniel; Bavli, Yaelle; Alon-Maimon, Tamar; Bachrach, Gilad; Wei, Xiaohui; Berman, Bella; Yassour, Moran; Cedrone,Edward; Neun,Barry; Dobrovolskaia,Marina; Clogston,Jeffrey; Stern,Steve; Barenholz, Yechezkel
  3. Journal of Controlled Release : official journal of the Controlled Release Society. 2024, Aug 2; 373: 713-726.
  1. 4.   "A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccination"
  2. Khalid, Muhammad B; Zektser, Ellen; Chu,Eric; Li, Min; Utoh, Joanna; Ryan, Patrick; Loving, Hanna S; Harb, Roa; Kattappuram, Robbie; Chatman, Lindsay; Hartono, Stella; Claudio-Etienne, Estefania; Sun, Guangping; Feener, Edward P; Li, Zhongbo; Lai, Samuel K; Le, Quang; Schwartz, Lawrence B; Lyons, Jonathan J; Komarow, Hirsh; Zhou, Zhao-Hua; Raza, Haniya; Pao, Maryland; Laky, Karen; Holland, Steven M; Brittain, Erica; Frischmeyer-Guerrerio, Pamela A
  3. The journal of Allergy and Clinical Immunology. . 2024, Jun; 153(6): 1634-1646.
  1. 5.   Stealth oxime ether lipid vesicles promote delivery of functional DsiRNA in human lung cancer A549 tumor bearing mouse xenografts
  2. Puri,Anu; Ibrahim, Faisal; O'Reilly Beringhs, André; Isemann, Camryn; Zakrevsky, Paul; Whittenburg, Abigail; Hargrove, Derek; Kanai,Tapan; Dillard, Rebecca S; de Val, Natalia; Nantz, Michael H; Lu, Xiuling; Shapiro,Bruce
  3. Nanomedicine : nanotechnology, biology, and medicine. 2022, Jun 04; 102572.
  1. 6.   Role of stealth lipids in nanomedicine-based drug carriers
  2. Rastogi, Mehak; Saha, Ranendra Narayan; Alexander, Amit; Singhvi, Gautam; Puri,Anu; Dubey, Sunil Kumar
  3. Chemistry and Physics of Lipids. 2021, Mar; 235
  1. 7.   Pilot Trial AMC-063: Safety and Efficacy of Bortezomib in AIDS-associated Kaposi Sarcoma
  2. Reid, Erin G; Suazo, Adrienne; Lensing, Shelly Y; Dittmer, Dirk P; Ambinder, Richard F; Maldarelli, Frank; Gorelick,Robert; Aboulafia, David M; Mitsuyasu, Ronald; Dickson, Mark A; Wachsman, William
  3. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020, FEB; 26(3): 558-565.
  1. 8.   PEGylated Liposomal Methyl Prednisolone Succinate does not Induce Infusion Reactions in Patients: A Correlation Between in Vitro Immunological and in Vivo Clinical Studies
  2. Bavli, Yaelle; Chen, Bing-Mae; Roffler, Steve R; Dobrovolskaia,Marina; Elnekave, Eldad; Ash, Shifra; Barenholz, Yechezkel; Turjeman, Keren
  3. Molecules (Basel, Switzerland). 2020, Jan 28; 25(3): pii: molecules25030558.
  1. 9.   Redox-responsive polymer inhibits macrophages uptake for effective intracellular gene delivery and enhanced cancer therapy
  2. Wen, Lijuan; Hu, Yingwen; Meng, Tingling; Tan, Yanan; Zhao, Mengdan; Dai, Suhuan; Yuan, Hong; Hu, Fuqiang
  3. Colloids and surfaces. B, Biointerfaces. 2019, Mar 1; 175: 392-402.
  1. 10.   Kaposi sarcoma
  2. Cesarman, Ethel; Damania, Blossom; Krown, Susan E.; Martin, Jeffrey; Bower, Mark; Whitby,Denise
  3. NATURE REVIEWS DISEASE PRIMERS. 2019, Jan 31; 5(1):
  1. 11.   Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro
  2. Neun, Barry; Barenholz, Yechezkel; Szebeni, Janos; Dobrovolskaia, Marina
  3. Molecules. 2018, Jul 12; 23(7): pii: E1700.
  1. 12.   Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer
  2. Burks, Julian; Nadella, Sandeep; Mahmud, Abdullah; Mankongpaisarnrung, Charoen; Wang, Juan; Hahm, Jong-In; Tucker, Robin D; Shivapurkar, Narayan; Stern, Steve; Smith, Jill P
  3. Cellular and Molecular Gastroenterology and Hepatology. 2018, Mar 07; 6(1): 17-32.
  1. 13.   Zeta potential: a case study of cationic, anionic, and neutral liposomes
  2. Smith, Mackensie C; Crist, Rachael; Clogston, Jeffrey; McNeil, Scott
  3. Analytical and bioanalytical chemistry. 2017, Sep; 409(24): 5779-5787.
  1. 14.   Purification of inclusion bodies using PEG precipitation under denaturing conditions to produce recombinant therapeutic proteins from Escherichia coli
  2. Chen, Huanhuan; Li, Ninghuan; Xie, Yueqing; Jiang, Hua; Yang, Xiaoyi; Cagliero, Cedric; Shi, Siwei; Zhu, Chencen; Luo, Han; Chen, Junsheng; Zhang, Lei; Zhao, Menglin; Feng, Lei; Lu, Huili; Zhu, Jianwei
  3. Applied Microbiology and Biotechnology. 2017, Jul; 101(13): 5267-5278.
  1. 15.   Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancer
  2. Shmeeda, Hilary; Amitay, Yasmine; Gorin, Jenny; Tzemach, Dina; Mak, Lidia; Stern, Steve; Barenholz, Yechezkel; Gabizon, Alberto
  3. JOURNAL OF DRUG TARGETING. 2016, Nov; 24(9): 878-889.
  1. 16.   Controlled biodegradation of Self-assembling beta-hairpin Peptide hydrogels by proteolysis with matrix metalloproteinase-13
  2. Giano, M. C.; Pochan, D. J.; Schneider, J. P.
  3. Biomaterials. 2011, Sep; 32(27): 6471-6477.
  1. 17.   Twice-weekly pegylated interferon-alpha-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy
  2. Murphy, A. A.; Herrmann, E.; Osinusi, A. O.; Wu, L.; Sachau, W.; Lempicki, R. A.; Yang, J.; Chung, T. L.; Wood, B. J.; Haagmans, B. L.; Kottilil, S.; Polis, M. A.
  3. Aids. 2011, Jun; 25(9): 1179-1187.
  1. 18.   Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma
  2. Uldrick, T. S.; Whitby, D.
  3. Cancer Letters. 2011, Jun; 305(2): 150-162.
  1. 19.   Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa-2a in HIV-1-Monoinfected Participants: A Phase II Clinical Trial
  2. Asmuth, D. M.; Murphy, R. L.; Rosenkranz, S. L.; Lertora, J. J. L.; Kottilil, S.; Cramer, Y.; Chan, E. S.; Schooley, R. T.; Rinaldo, C. R.; Thielman, N.; Li, X. D.; Wahl, S. M.; Shore, J.; Janik, J.; Lempicki, R. A.; Simpson, Y.; Pollard, R. B.; Tea, A. C. T. G. A.
  3. Journal of Infectious Diseases. 2010, Jun 1; 201(11): 1686-1696.
  1. 20.   Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-(AuNP)-Au-198 nanoconstruct in prostate tumor-bearing mice
  2. Chanda, N.; Kan, P.; Watkinson, L. D.; Shukla, R.; Zambre, A.; Carmack, T. L.; Engelbrecht, H.; Lever, J. R.; Katti, K.; Fent, G. M.; Casteel, S. W.; Smith, C. J.; Miller, W. H.; Jurisson, S.; Boote, E.; Robertson, J. D.; Cutler, C.; Dobrovolskaia, M.; Kannan, R.; Katti, K. V.
  3. Nanomedicine-Nanotechnology Biology and Medicine. 2010, Apr; 6(2): 201-209.
  1. 21.   Minireview: Nanoparticles and the Immune System
  2. Zolnik, B. S.; Gonzalez-Fernandez, A.; Sadrieh, N.; Dobrovolskaia, M. A.
  3. Endocrinology. 2010, Feb; 151(2): 458-465.
  1. 22.   Various drug delivery approaches to the central nervous system
  2. Pasha, S.; Gupta, K.
  3. Expert Opinion on Drug Delivery. 2010, Jan; 7(1): 113-135.
  1. 23.   Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
  2. Puri, A.; Loomis, K.; Smith, B.; Lee, J. H.; Yavlovich, A.; Heldman, E.; Blumenthal, R.
  3. Critical Reviews in Therapeutic Drug Carrier Systems. 2009 26(6): 523-580.
  1. 24.   Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles
  2. Dobrovolskaia, M. A.; Patri, A. K.; Zheng, J. W.; Clogston, J. D.; Ayub, N.; Aggarwal, P.; Neun, B. W.; Hall, J. B.; McNeil, S. E.
  3. Nanomedicine-Nanotechnology Biology and Medicine. 2009 5(2): 106-117.
  1. 25.   Variants in Interferon-Alpha Pathway Genes and Response to Pegylated Interferon-Alpha2a Plus Ribavirin for Treatment of Chronic Hepatitis C Virus Infection in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial
  2. Welzel, T. M.; Morgan, T. R.; Bonkovsky, H. L.; Naishadham, D.; Pfeiffer, R. M.; Wright, E. C.; Hutchinson, A. A.; Crenshaw, A. T.; Bashirova, A.; Carrington, M.; Dotrang, M.; Sterling, R. K.; Lindsay, K. L.; Fontana, R. J.; Lee, W. M.
  3. Hepatology. 2009 49(6): 1847-1858.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel